logo

COCH

Envoy Medical·NASDAQ
--
--(--)
--
--(--)

COCH fundamentals

Envoy Medical (COCH) released its earnings on Nov 10, 2025: revenue was 42.00K (YoY -25.00%), missed estimates; EPS was -0.35 (YoY +5.41%), missed estimates.
Revenue / YoY
42.00K
-25.00%
EPS / YoY
-0.35
+5.41%
Report date
Nov 10, 2025

Earnings

EPS
Revenue

Revenue & Expenses

COCH has released its 2025 Q4 earnings report, with revenue of 75.00K, reflecting a YoY change of 78.57%, and net profit of -6.59M, showing a YoY change of -42.62%. The Sankey diagram below clearly presents COCH's revenue sources and cost distribution.

Key Indicators

Envoy Medical (COCH) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Envoy Medical (COCH)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown

Balance Sheet

Envoy Medical (COCH)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown

Cash Flow

Envoy Medical (COCH)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown

Revenue Breakdown

Where does Envoy Medical (COCH) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:

Dividend

Track Envoy Medical (COCH) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield